Rankings
▼
Calendar
UTHR FY 2011 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$743M
+23.1% YoY
Gross Profit
$654M
88.0% margin
Operating Income
$318M
42.8% margin
Net Income
$218M
29.3% margin
EPS (Diluted)
$3.67
Cash Flow
Operating Cash Flow
$250M
Free Cash Flow
$214M
Stock-Based Comp.
-$16M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$570M
Stockholders' Equity
$948M
Cash & Equivalents
$163M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$743M
$604M
+23.1%
Gross Profit
$654M
$530M
+23.4%
Operating Income
$318M
$164M
+93.8%
Net Income
$218M
$106M
+105.7%
← FY 2010
All Quarters
FY 2012 →